文献

J-GLOBAL ID：201402209112705757   整理番号：14A0272599

線維芽細胞増殖因子-5が肝線維症の進行に関係する

Fibroblast Growth Factor-5 Participates in the Progression of Hepatic Fibrosis

著者 (8件)： HANAKA Hiromi (Dep. of Developmental Anatomy and Regenerative Biology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa ...) ,  HAMADA Tsuyoshi (Dep. of Anatomy and Neurobiology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa, Saitama 359-8513, JPN) ,  ITO Masataka (Dep. of Developmental Anatomy and Regenerative Biology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa ...) ,  NAKASHIMA Hiroyuki (Dep. of Immunology and Microbiology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa, Saitama 359-8513, JPN) ,  TOMITA Kengo (Div. of Gastroenterology and Hepatology, Dep. of Internal Medicine, National Defense Medical Coll., 3-2 Namiki ...) ,  SEKI Shuhji (Dep. of Immunology and Microbiology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa, Saitama 359-8513, JPN) ,  KOBAYASHI Yasushi (Dep. of Anatomy and Neurobiology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa, Saitama 359-8513, JPN) ,  IMAKI Junko (Dep. of Developmental Anatomy and Regenerative Biology, National Defense Medical Coll., 3-2 Namiki, Tokorozawa ...)
資料名： Experimental Animals  (Experimental Animals)
巻： 63  号： 1  ページ： 85-92 (J-STAGE)  発行年： 2014年 
JST資料番号： Z0755A  ISSN： 1341-1357  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 非アルコール性脂肪性肝炎(NASH)は脂肪肝,炎症,線維症に...

シソーラス用語： マウス ,...
準シソーラス用語： *FGF5 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0272599&from=J-GLOBAL&jstjournalNo=Z0755A") }}

分類 (3件)： 消化器の基礎医学  (GH01020E) ,  肝臓  (EJ06060J) ,  生物学的機能  (EB03040U)

引用文献 (24件)：

• 1. Afdhal N.H. 2012. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? JAMA. 308: 608-616.
• 2. Allerstorfer S., Sonvilla G., Fischer H., Spiegl-Kreinecker S., Gauglhofer C., Setinek U., Czech T., Marosi C., Buchroithner J., Pichler J., Silye R., Mohr T., Holzmann K., Grasl-Kraupp B., Marian B., Grusch M., Fischer J., Micksche M., and Berger W. 2008. FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene 27: 4180-4190.
• 3. Angulo P., Keach J.C., Batts K.P., and Lindor K.D. 1999. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356-1362.
• 4. Bacon B.R., Farahvash M.J., Janney C.G., and Neuschwander-Tetri B.A. 1994. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103-1109.
• 5. Bieghs V., van Gorp P.J., Walenbergh S.M., Gijbels M.J., Verheyen F., Buurman W.A., Briles D.E., Hofker M.H., Binder C.J., and Shiri-Sverdlov R. 2012. Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice. Hepatology 56: 894-903.

タイトルに関連する用語 (2件)： 線維芽細胞増殖因子 ,  肝線維症